GSK shares fell more than 5% after U.S. health officials narrowed their recommendation of respiratory syncytial virus vaccines to a smaller age range and more at-risk patients.
Related Posts
TSMC Posts Stronger Second-Quarter Profit on Chip Demand
Taiwan Semiconductor Manufacturing Co.’s second-quarter net profit jumped on surging demand for advanced chips amid the global artificial-intelligence boom.
Go Woke, Go Broke? Not a Chance, Say Ben and Jerry
The founders of Ben & Jerry’s speak about mixing politics with business, the ice cream brand’s future, and why Ozempic doesn’t worry them.
Carlsberg’s Improved Offer for Britvic Rejected
Carlsberg said it was considering its position after Britvic rejected an improved offer valuing the U.K. soft-drinks maker at more than $3.9 billion.